Ameriprise Financial Inc Theravance Biopharma, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 111,632 shares of TBPH stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

111,632

Previous 111,382 0.22%

Holding current value

$1.1 Million

Previous $944,000 4.77%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.66 - $10.25 $1,915 - $2,562	250 Added 0.22%	111,632 $899,000
Q2 2024 Aug 14, 2024	SELL	$8.29 - $9.92 $3,233 - $3,868	-390 Reduced 0.35%	111,382 $944,000
Q1 2024 May 15, 2024	BUY	$8.22 - $11.59 $644,390 - $908,574	78,393 Added 234.86%	111,772 $1 Million
Q4 2023 Feb 14, 2024	BUY	$8.58 - $11.4 $286,391 - $380,520	33,379 New	33,379 $375,000
Q1 2023 May 15, 2023	BUY	$9.87 - $11.44 $5,921 - $6,864	600 Added 3.65%	17,030 $184,000
Q4 2022 Feb 14, 2023	BUY	$9.65 - $11.34 $158,549 - $186,316	16,430 New	16,430 $184,000
Q3 2021 Nov 15, 2021	SELL	$6.77 - $14.41 $76,568 - $162,977	-11,310 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$14.52 - $22.46 $59,836 - $92,557	-4,121 Reduced 26.71%	11,310 $164,000
Q1 2021 May 17, 2021	SELL	$16.57 - $21.08 $5.47 Million - $6.96 Million	-330,075 Reduced 95.53%	15,431 $315,000
Q4 2020 Feb 12, 2021	SELL	$14.89 - $20.16 $1.68 Million - $2.27 Million	-112,537 Reduced 24.57%	345,506 $6.14 Million
Q3 2020 Nov 16, 2020	SELL	$14.79 - $22.49 $15.5 Million - $23.5 Million	-1,044,830 Reduced 69.52%	458,043 $6.77 Million
Q2 2020 Aug 14, 2020	SELL	$20.64 - $30.69 $1.52 Million - $2.27 Million	-73,842 Reduced 4.68%	1,502,873 $31.5 Million
Q1 2020 May 15, 2020	BUY	$17.84 - $31.21 $21.9 Million - $38.3 Million	1,226,134 Added 349.74%	1,576,715 $36.4 Million
Q4 2019 Feb 14, 2020	SELL	$16.12 - $25.89 $1.12 Million - $1.79 Million	-69,186 Reduced 16.48%	350,581 $9.08 Million
Q3 2019 Nov 14, 2019	SELL	$16.51 - $23.78 $690,002 - $993,837	-41,793 Reduced 9.05%	419,767 $8.18 Million
Q2 2019 Aug 14, 2019	BUY	$15.6 - $25.15 $7.2 Million - $11.6 Million	461,560 New	461,560 $7.54 Million

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $658M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Theravance Biopharma, Inc. Transaction History